Scientific Protein Laboratories, LLC

Dustin Nielsen

Anisha Akula

Yan Wang

Karla Anhalt

Kenneth S Manning

Ryan Ruf

Colin Crowley

Jon Restivo

Dana Spangenberg

Mark Romich

Carmen Fritz

Rachel W Wezeman

Lin Rao

Matthew Bristol

Mark Eifler

Lisa Petersen

Erik Walke

A pancreatin preparation having reduced viral infectivity includes one or more pancreatin enzymes and peracetic acid (PAA). At least one pancreatin enzyme may be derived from an animal source such as a porcine pancreas gland. In a particular embodiment, the one or more pancreatin enzymes are selected from the group consisting of lipases, proteases, and amylases.

Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin

A method for the reduction or inactivation of viral and microbial content in the manufacturing of pancreatin API is disclosed. The method includes treating animal-derived tissue with peracetic acid to reduce viral activity and bacterial load prior to processing. In particular, the method includes treating porcine pancreas glands with peracteic acid prior to extracting a pancreatin API from the treated glandular tissue.

Disclosed is a method for the determination of the absence or presence ofenterotoxin in a protein sample via a western blot.

[object Object]

Growing community of inventors

Santa Barbara, CA, United States of America

Dustin Nielsen